Godsey & Gibb Inc’s GSK GSK Stock Holding History

Godsey & Gibb Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-56	Closed	-$2.29K	–	395
2024 Q3	$2.29K	Buy	+56	New	+$2.29K	﹤0.01%	401
2023 Q4	–	Sell	-1,280	Closed	-$46.4K	–	367
2023 Q3	$46.4K	Hold	1,280	–	–	0.01%	163
2023 Q2	$45.6K	Hold	1,280	–	–	0.01%	174
2023 Q1	$45.5K	Sell	1,280 -428	-25%	-$15K	0.01%	171
2022 Q4	$60K	Buy	+1,708	New	+$56.9K	0.01%	108
2022 Q2	–	Sell	-1,280	Closed	-$70K	–	132
2022 Q1	$70K	Buy	+1,280	New	+$69.5K	0.03%	46

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Godsey & Gibb Inc's GSK Position: Q4 2024 in Review

Godsey & Gibb Inc sold out of GSK (GSK) in Q4 2024, closing a stake of 56 shares — an estimated $2.29K sold.

Godsey & Gibb Inc first reported a position in GSK in Q1 2022 and held it in 6 quarters. The position peaked at $70K in Q1 2022. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Godsey & Gibb Inc reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Godsey & Gibb Inc sold 56 GSK shares in Q4 2024, an estimated $2.29K.
Godsey & Gibb Inc first reported a position in GSK in Q1 2022 and held it in 6 quarters.
Godsey & Gibb Inc's GSK position peaked at $70K in Q1 2022.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Godsey & Gibb Inc's 13F filing for Q4 2024, filed 14 Jan 2025.